Virginia International Raceway started with a lot of promise. Both cars were fast in practice, and the team seemed to be getting the setups where they needed to be. The No. 46 qualified P5. The No. 64 qualified P28 overall and P2 in Bronze. We had two good cars and two good opportunities. Then racing happened.

Healthcare is rarely out of the headlines. One day, the conversation centers on rising costs. The next, it’s physician shortages, access to care, insurance reform, or the latest medical breakthrough. Each issue deserves attention because every one affects patients in meaningful ways. But amid all of these discussions, I think we sometimes lose sight of a more fundamental question.

When people think about medical breakthroughs, they often think about the discovery itself. A new therapy. A promising clinical trial. A scientific advancement that changes the way we understand disease. What often gets overlooked is where those breakthroughs begin. They usually start with people. Specifically, researchers willing to spend years asking difficult questions, testing ideas, and pursuing answers that may not come easily.

But what they don’t see is the grind behind the scenes. The years of effort, the research that doesn’t get funded, and the scientists struggling to keep momentum without institutional support.

You don’t usually associate spreadsheets with survival rates. But that’s exactly the connection Dr. Paul Macklin is exploring in our latest Driving Research episode.

We throw the word legacy around a lot. People use it to mean all kinds of things: a name on a building, a career full of accolades, a foundation that writes checks in your honor. But in my experience, real legacy isn’t about how things look. It’s about whether what you built keeps working when you’re no longer in the picture. In cancer research, that’s especially important. If your funding, your connections, or your ideas are holding everything together, then you’re not build

For years, I’ve funded cancer research behind the scenes. Now, we’re taking the conversation public, with the launch of Driving Research, the JKTG Foundation’s first-ever cancer research podcast. And we’re starting with a conversation that matters...